Changes in the Practice of Coronary Revascularization between 2006 and 2010 in the Republic of Korea

Yoon Jung Choi1, Jin-Bae Kim2, Su-Jin Cho1

  • 1Health Technology Assessment Team, Health Insurance Review and Assessment Service, Seoul, Korea.

Insights

Coronary revascularization increased in Korea from 2006-2010, with more percutaneous coronary intervention (PCI) and fewer coronary artery bypass graft (CABG) surgeries. In-hospital mortality rose for PCI but fell for CABG.

Area of Science:

  • Cardiovascular Medicine
  • Health Services Research
  • Medical Economics

Background:

  • Technological advancements and National Health Insurance Service reimbursement schemes may influence coronary artery disease management.
  • Understanding shifts in coronary revascularization practices is crucial for healthcare policy and patient outcomes.

Purpose of the Study:

  • To investigate changes in the practice patterns of coronary revascularization in Korea.
  • To analyze trends in percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) surgery rates.
  • To examine in-hospital mortality associated with these procedures.

Main Methods:

  • Analysis of medical claims data for Korean patients aged 20 and above from 2006 to 2010.
  • Calculation of age- and sex-standardized coronary revascularization rates per 100,000 person-years.
  • Comparison of procedure rates, stent utilization, and in-hospital mortality between PCI and CABG.

Main Results:

  • Coronary revascularization rates increased from 116.1 to 131.0 per 100,000 person-years between 2006 and 2010.
  • Percutaneous coronary intervention (PCI) rates increased by 16%, while coronary artery bypass graft (CABG) surgery rates decreased by 20%.
  • Drug-eluting stent use in PCI rose from 89.1% to 93.0%; in-hospital mortality increased for PCI (p=0.03) but decreased for CABG (p=0.01).
  • Higher in-hospital mortality was observed in elderly and female patients, and at lower-volume hospitals for both PCI and CABG.

Conclusions:

  • Coronary revascularization volume in Korea showed a continuous annual increase from 2006 to 2010, with procedural trends varying by type.
  • A high proportion of drug-eluting stent use in PCI procedures was observed.
  • Higher in-hospital mortality rates at low-volume hospitals highlight potential quality disparities in care.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...